Vertex Pharmaceuticals Incorporated
Utility Patent Applications
Last updated:
List of all Vertex Pharmaceuticals Incorporated patents 91 in total
| Status | Patent |
|---|---|
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES Filling date: 12 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: METHOD FOR TREATING CANCER USING A COMBINATION OF CHK1 AND ATR INHIBITORS Filling date: 12 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: ENHANCED DIFFERENTIATION OF BETA CELLS Filling date: 12 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR EDITING BETA-GLOBIN FOR TREATMENT OF HEMAGLOBINOPATHIES Filling date: 12 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES Filling date: 12 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: Compositions and Methods for Treatment of Disorders Associated with Repetitive DNA Filling date: 12 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: METHODS, COMPOSITIONS AND KITS FOR INCREASING GENOME EDITING EFFICIENCY Filling date: 12 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators Filling date: 12 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: Compositions and Methods for Treatment of Duchenne Muscular Dystrophy Filling date: 12 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: DIFFERENTIATION OF PANCREATIC ENDOCRINE CELLS Filling date: 12 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: METHOD FOR TREATING CANCER USING A COMBINATION OF DNA-DAMAGING AGENTS AND DNA-PK INHIBITORS Filling date: 12 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: METHODS OF TREATMENT FOR CYSTIC FIBROSIS Filling date: 12 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Filling date: 12 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL) BENZOIC ACID AND ADMINISTRATION THEREOF Filling date: 12 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: GENE-EDITING SYSTEMS FOR EDITING A CYSTIC FIBROSIS TRANSMEMBRANE REGULATOR (CFTR) GENE Filling date: 12 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES Filling date: 12 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS Filling date: 12 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: METHODS OF ENHANCING STEM CELL DIFFERENTIATION INTO BETA CELLS Filling date: 12 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: METHODS OF CANCER TREATMENT USING AN ATR INHIBITOR Filling date: 12 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: MODULATORS OF ALPHA-1 ANTITRYPSIN Filling date: 12 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES Filling date: 12 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: DEUTERATED PYRIDONE AMIDES AND PRODRUGS THEREOF AS MODULATORS OF SODIUM CHANNELS Filling date: 12 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Filling date: 12 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: METHODS OF TREATMENT FOR CYSTIC FIBROSIS Filling date: 12 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS Filling date: 12 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: DNA-PK INHIBITORS Filling date: 12 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS Filling date: 12 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: DNA-PK INHIBITORS Filling date: 12 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Filling date: 12 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: A METHOD OF TREATING PAIN Filling date: 12 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: MODULATOR OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: PROCESS OF MAKING CFTR MODULATORS Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: CRYSTALLINE FORMS OF CFTR MODULATORS Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: CRISPR/CAS ALL-IN-TWO VECTOR SYSTEMS FOR TREATMENT OF DMD Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: GCN2 INHIBITORS AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Filling date: 12 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR Filling date: 12 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF Filling date: 12 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS Filling date: 12 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: IMPLANTATION DEVICES, SYSTEM, AND METHODS Filling date: 12 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: FORMULATIONS OF AZAINDOLE COMPOUNDS Filling date: 12 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES Filling date: 12 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: CRYSTALLINE FORMS OF MODULATORS OF CFTR Filling date: 12 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: TREATING CANCER WITH ATR INHIBITORS Filling date: 12 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: CRYSTALLINE FORMS AND COMPOSITIONS OF CFTR MODULATORS Filling date: 12 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: CRISPR-CAS9 MODIFIED CD34+ HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: PRODRUGS OF PYRIDONE AMIDES USEFUL AS MODULATORS OF SODIUM CHANNELS Filling date: 12 Sep 2025 Issue date: 3 Dec 2020 |
Showing 1 to 50 of 91 patents.